Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | NVP-TAE 226 REF: 54-BUP02589CAS: 761437-28-9 | 98.07% | 401.00 €~833.00 € | Thu 17 Apr 25 |
![]() | NVP-TAE 226 REF: TM-T1918CAS: 761437-28-9 | 98.07% - 98.78% | 48.00 €~567.00 € | Wed 23 Apr 25 |
![]() | NVP TAE 226 REF: 3D-FT153807CAS: 761437-28-9 | Min. 95% | 331.00 €~896.00 € | Wed 28 May 25 |

Ref: 54-BUP02589
25mg | 401.00 € | ||
50mg | 563.00 € | ||
100mg | 833.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025

NVP-TAE 226
CAS:761437-28-9
NVP-TAE 226: Potent FAK inhibitor, IC50=5.5nM, stronger vs Pyk2, IC50=3.5nM, weaker against IGF-1R, InsR, c-Met, …
Formula:
C23H25ClN6O3
Purity:
98.07% - 98.78%
Color and Shape:
Solid
Molecular weight:
468.94
- Inhibitors
- FAK
- Apoptosis
- PYK2
- See more categories
- IGF-1R
Ref: TM-T1918
1mg | 48.00 € | ||
2mg | 63.00 € | ||
5mg | 101.00 € | ||
10mg | 163.00 € | ||
25mg | 264.00 € | ||
50mg | 378.00 € | ||
100mg | 567.00 € | ||
1mL*10mM (DMSO) | 101.00 € |
Estimated delivery in United States, on Wednesday 23 Apr 2025

NVP TAE 226
CAS:761437-28-9
Dual FAK/IGF1R kinase inhibitor; anti-cancer agent
Formula:
C23H25ClN6O3
Purity:
Min. 95%
Molecular weight:
468.94 g/mol
Ref: 3D-FT153807
10mg | 331.00 € | ||
50mg | 896.00 € |
Estimated delivery in United States, on Wednesday 28 May 2025